These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3662453)

  • 1. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
    Mesulam MM; Asuncion Morán M
    Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
    Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
    Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM; Geula C; Morán MA
    Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
    Geula C; Mesulam M
    Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropathological changes associated with normal brain aging.
    Hof PR; Glannakopoulos P; Bouras C
    Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease].
    Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA
    Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterases in the amyloid angiopathy of Alzheimer's disease.
    Mesulam M; Carson K; Price B; Geula C
    Ann Neurol; 1992 May; 31(5):565-9. PubMed ID: 1375822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease.
    Shen ZX
    Med Hypotheses; 2004; 63(2):285-97. PubMed ID: 15236793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
    Gómez-Isla T; Hollister R; West H; Mui S; Growdon JH; Petersen RC; Parisi JE; Hyman BT
    Ann Neurol; 1997 Jan; 41(1):17-24. PubMed ID: 9005861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
    Smith MA; Kutty RK; Richey PL; Yan SD; Stern D; Chader GJ; Wiggert B; Petersen RB; Perry G
    Am J Pathol; 1994 Jul; 145(1):42-7. PubMed ID: 8030754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.
    Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O
    Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.
    Yamamoto T; Hirano A
    Ann Neurol; 1985 Jun; 17(6):573-7. PubMed ID: 4026228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
    J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
    Grudzien A; Shaw P; Weintraub S; Bigio E; Mash DC; Mesulam MM
    Neurobiol Aging; 2007 Mar; 28(3):327-35. PubMed ID: 16574280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.
    Morán MA; Mufson EJ; Gómez-Ramos P
    Acta Neuropathol; 1994; 87(3):284-92. PubMed ID: 8009960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.